Code: 04084569

Anticancer Therapeutics

Name: Anticancer Therapeutics
Brand: John Wiley & Sons Inc
SKU: 04084569
Price: 232.08 EUR
Availability: BackOrder

by Missailidis

Language: English
Binding: Hardback
Number of pages: 424
Publisher: John Wiley & Sons Inc, 2008
More about this

232.08 €

Availability:

50/50

We think title might be available. Upon your order we will do our best to get it within 6 weeks.
We search the world

Availability alert

Add to wishlist

Anticancer
18.70 € -23 %
Buy
Forming a Limited Company
30.46 €
Buy
European Union and its Order - The Legal Theory of European Integration
85.26 €
Buy
Finding Gold in the Desert
9.09 € -12 %
Buy
Effective Health Behavior in Older Adults
123.60 €
Buy
Final Crisis of the Stuart Monarchy
49.68 €
Buy
Environmental Management
209.28 €
Buy

Give this book as a present today

Order book and choose Gift Order.
We will send you book gift voucher at once. You can give it out to anyone.
Book will be send to donee, nothing more to care about.

Book gift voucher sample Read more

Availability alert

We will watch availability for you

Enter your e-mail address and once book will be available,
we will send you a message. It's that simple.

You get 574 loyalty points

Book synopsis

Written by the winner of the 2008 Mike Price Fellowship "This volume provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject." Anticancer Research, November - December 2008 This book provides a clear introduction to the area, with an overview of the various drug design and development approaches for cancer therapeutics and their progress in today's multidisciplinary approach to cancer treatment. Clearly structured throughout, the book not only provides information on currently used molecular treatment approaches, but also describes the various agents that are currently at various stages of development and clinical trials, thus making them the drugs of tomorrow. The book goes on to present current therapeutic regimes including their indications and side effects, as well as their position in the international market in terms of sales and development costs. Furthermore, coverage of our advancement in the understanding of cancer biology and how this has driven the drug discovery process is clearly discussed. Modern drug discovery aspects, through genomic, proteomic and metabolomic approaches are referred to as well as combinatorial chemistry techniques and discovery of chemotherapeutic agents from plant extracts, re-use of old drugs and drugs from other indications, or de novo rational drug design. Including contributions from leading experts in the field, this book provides the reader with a complete overview of the various types of therapeutic agents, current and emerging, as well as other aspects associated with anticancer therapy, drug design, resistance and clinical trials in oncology.